Brooklyn Investment Group Purchases New Position in CME Group Inc. (NASDAQ:CME)

Brooklyn Investment Group acquired a new position in CME Group Inc. (NASDAQ:CME) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,266 shares of the financial services provider’s stock, valued at approximately $279,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Truvestments Capital LLC purchased a new stake in CME Group during the third quarter worth $26,000. Y.D. More Investments Ltd acquired a new position in shares of CME Group in the second quarter worth about $36,000. Thurston Springer Miller Herd & Titak Inc. grew its position in shares of CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares during the period. McClarren Financial Advisors Inc. increased its stake in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares in the last quarter. Finally, Asset Dedication LLC raised its holdings in CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares in the company, valued at approximately $1,652,298. This trade represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,621 shares of company stock valued at $3,441,063. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on CME shares. Citigroup raised their price objective on CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. Morgan Stanley upped their price objective on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. Oppenheimer lifted their target price on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. Piper Sandler upped their price target on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Finally, Bank of America lifted their price objective on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $224.47.

CME Group Stock Performance

NASDAQ CME opened at $234.39 on Wednesday. The stock has a fifty day simple moving average of $224.18 and a 200-day simple moving average of $211.37. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market cap of $84.47 billion, a PE ratio of 24.65, a P/E/G ratio of 5.28 and a beta of 0.55. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $235.18.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the firm posted $2.25 earnings per share. CME Group’s revenue was up 18.4% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 1.96%. CME Group’s dividend payout ratio is presently 48.37%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.